Balaxi Pharmaceuticals Ltd Share Price (BALAXI)
as on
| Source : NSE
Balaxi Pharmaceuticals Ltd Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹47.57₹48.77
0.29%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
₹42.56₹127.4510.79%
Downside
167.13%
Upside
| Market Stats | |
| Previous Close | ₹48.75 |
| Open | ₹48.24 |
| Volume | 65.70K |
| Upper Circuit | ₹58.50 |
| Lower Circuit | ₹39.00 |
| Day's Low | ₹47.57 |
| Day's High | ₹48.77 |
| 52 Week Low | ₹42.56 |
| 52 Week High | ₹127.45 |
| Returns % | |
| 1 Month Return | -2.73 % |
| 3 Month Return | -12.33 % |
| 1 Year Return | -56.79 % |
| 3 Year Return | -45.59 % |
| 5 Year Return | -35.33 % |
Balaxi Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Balaxi Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹263.39 Cr
Return on Equity (ROE)
2.89
PE Ratio (TTM)
13.95
Return on capital employed (ROCE)
5.06
Industry PE ratio
43.28
Beta (LTM)
0.99
P/B Ratio
2.76
Dividend Yield
0PEG Ratio
-2.63
Quarterly Earnings Growth YOY
-95.52
EPS (TTM)
4.54
Sector
Pharmaceuticals
Book Value
41.98
Technical Analysis
Bearish
View Technical Analysis
Balaxi Pharmaceuticals Ltd Stock's Interest Amongst Investors
Balaxi Pharmaceuticals Ltd Stock Valuation
Track how Balaxi Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Balaxi Pharmaceuticals Ltd in the last 5 years
Lowest (-263.96x)
May 28, 2024
Today (13.95x)
August 14, 2025
Industry (43.28x)
August 14, 2025
Highest (66.45x)
September 21, 2020
Today’s Price to Earnings Ratio: 13.95x
Balaxi Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Balaxi Pharmaceuticals Ltd, including revenue, profit, loss and more.
Balaxi Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Balaxi Pharmaceuticals Ltd.
Balaxi Pharmaceuticals Ltd Earnings Results
Balaxi Pharmaceuticals Ltd’s net profit fell -95.52% since last year same period to ₹0.29Cr in the Q1 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -96.64% fall in its net profits since last 3-months.
Read More about Earnings ResultsBalaxi Pharmaceuticals Ltd Dividends May,2022
In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 per share on 23 May 2022 - translating a dividend yield of 1.05%.
Read More about Dividends
Balaxi Pharmaceuticals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Balaxi Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 65.99% | 0.00 | |
| Foreign Institutions | 8.87% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 25.12% | 39.85 | |
| Others | 0.02% | 0.42 |
Balaxi Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Balaxi Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 263.39 | -7.07% | 0.59 | 25 | 292 | |
| NA | 138.38 | -10.52% | 0.00 | 12 | 69 | |
| NA | 48.85 | -16.67% | 0.00 | -22 | 104 | |
| NA | 48.17 | 105.43% | 0.00 | -1 | NA | |
| NA | 496.33 | 21.03% | 0.00 | NA | NA |
Balaxi Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Balaxi Pharmaceuticals Ltd.
Balaxi Pharma Reports Significant Decline in Financials - 24 Jun, 2025
Balaxi Pharma's March 2025 net sales fell 39.33% year-on-year to Rs 9.65 crore, with a net loss of Rs 1.18 crore. The stock has declined 32.32% over the last six months and 58.62% over the past year.Balaxi Pharmaceuticals Stock Surges on Expansion Plans - 09 Jun, 2025
Balaxi Pharmaceuticals shares jumped over 10% following the announcement of its strategic expansion plans and strong financial results for FY25, despite a turbulent year. The company aims to enhance its market presence and operational capabilities, with a new manufacturing facility underway. Although the stock is down 54% year-on-year, recent gains indicate a recovery trend.Balaxi Pharmaceuticals Stock Surges Despite Losses - 02 Jun, 2025
Balaxi Pharmaceuticals shares jumped 10% on June 2, 2025, despite reporting a widened net loss of ₹117.85 lakh for Q4 FY25. The stock has lost over 58% in the past year, reflecting ongoing financial stress and declining revenues.
Insights on Balaxi Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 17.96% to 25.12% in Jun 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 65.99% of holdings in Jun 2025 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 8.64 Cr → 0.29 Cr (in ₹), with an average decrease of 96.6% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 77.23 Cr → 68.97 Cr (in ₹), with an average decrease of 5.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 year, BALAXI stock has moved down by -56.8%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.02% to 8.87% in Jun 2025 quarter
About Balaxi Pharmaceuticals Ltd
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.
Revenue: ₹70.74Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.29Cr as on June 2025 (Q1 FY26)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
| Organisation | Balaxi Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Ashish Maheshwari |
| E-voting on shares | Click here to vote |
FAQs
What is Balaxi Pharmaceuticals Ltd share price today?
Balaxi Pharmaceuticals Ltd share price today stands at ₹47.71, Open: ₹48.24, Previous Close: ₹48.75, High: ₹48.77, Low: ₹47.57, 52 Week High: ₹127.45, 52 Week Low: ₹42.56 as on .
How to buy Balaxi Pharmaceuticals Ltd shares ?
To buy Balaxi Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BALAXI or Balaxi Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Balaxi Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Balaxi Pharmaceuticals Ltd?
Today's traded volume of Balaxi Pharmaceuticals Ltd is 65.70K. Which means that 65.70K shares of Balaxi Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Balaxi Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Balaxi Pharmaceuticals Ltd is ₹263.39 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd’s 52 week high is ₹127.45 and 52 week low is ₹42.56. The current share price of Balaxi Pharmaceuticals Ltd is ₹47.71, which is -62.57% down from its 52 week high and 12.10% up from its 52 week low.